121 related articles for article (PubMed ID: 38649690)
1. Transcriptome and single-cell analysis reveal disulfidptosis-related modification patterns of tumor microenvironment and prognosis in osteosarcoma.
Wang L; Liu Y; Tai J; Dou X; Yang H; Li Q; Liu J; Yan Z; Liu X
Sci Rep; 2024 Apr; 14(1):9186. PubMed ID: 38649690
[TBL] [Abstract][Full Text] [Related]
2. Development of a Risk Model and Genotyping Patterns Based on Disulfidptosis-Related lncRNAs to Predict Prognosis and Immune Landscape in Osteosarcoma.
Zhang K; Lu S; Jiang M; Zou X; Chen C; Lan Y; Zhao H; Ma R; Yan H
Front Biosci (Landmark Ed); 2024 May; 29(5):193. PubMed ID: 38812298
[TBL] [Abstract][Full Text] [Related]
3. Unveiling the hidden role of disulfidptosis in kidney renal clear cell carcinoma: a prognostic signature for personalized treatment.
Ye Y; Zeng S; Hu X
Apoptosis; 2024 Jun; 29(5-6):693-708. PubMed ID: 38296888
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
[TBL] [Abstract][Full Text] [Related]
5. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
Front Immunol; 2021; 12():806189. PubMed ID: 35095893
[TBL] [Abstract][Full Text] [Related]
6. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
[TBL] [Abstract][Full Text] [Related]
7. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma cancer.
Liu R; Hu Y; Liu T; Wang Y
BMC Cancer; 2021 Dec; 21(1):1345. PubMed ID: 34922489
[TBL] [Abstract][Full Text] [Related]
8. Combined analysis of DNA methylation and gene expression profiles of osteosarcoma identified several prognosis signatures.
Tian W; Li Y; Zhang J; Li J; Gao J
Gene; 2018 Apr; 650():7-14. PubMed ID: 29407229
[TBL] [Abstract][Full Text] [Related]
9. Integrated transcriptomic analysis systematically reveals the heterogeneity and molecular characterization of cancer-associated fibroblasts in osteosarcoma.
Liu Y; Han X; Han Y; Bi J; Wu Y; Xiang D; Zhang Y; Bi W; Xu M; Li J
Gene; 2024 May; 907():148286. PubMed ID: 38367852
[TBL] [Abstract][Full Text] [Related]
10. Comparative Transcriptome Analysis Quantifies Immune Cell Transcript Levels, Metastatic Progression, and Survival in Osteosarcoma.
Scott MC; Temiz NA; Sarver AE; LaRue RS; Rathe SK; Varshney J; Wolf NK; Moriarity BS; O'Brien TD; Spector LG; Largaespada DA; Modiano JF; Subramanian S; Sarver AL
Cancer Res; 2018 Jan; 78(2):326-337. PubMed ID: 29066513
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive analysis of immune infiltration in the tumor microenvironment of osteosarcoma.
Yang H; Zhao L; Zhang Y; Li FF
Cancer Med; 2021 Aug; 10(16):5696-5711. PubMed ID: 34258887
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-505 is downregulated in human osteosarcoma and regulates cell proliferation, migration and invasion.
Liu YJ; Li W; Chang F; Liu JN; Lin JX; Chen DX
Oncol Rep; 2018 Feb; 39(2):491-500. PubMed ID: 29251324
[TBL] [Abstract][Full Text] [Related]
13. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
Front Immunol; 2022; 13():919231. PubMed ID: 35967366
[TBL] [Abstract][Full Text] [Related]
14. HMGB1 promotes cellular proliferation and invasion, suppresses cellular apoptosis in osteosarcoma.
Meng Q; Zhao J; Liu H; Zhou G; Zhang W; Xu X; Zheng M
Tumour Biol; 2014 Dec; 35(12):12265-74. PubMed ID: 25168370
[TBL] [Abstract][Full Text] [Related]
15. Identification of TNFRSF1A as a potential biomarker for osteosarcoma.
Zhang Y; Liu K; Wang J
Cancer Biomark; 2024; 39(4):299-312. PubMed ID: 38250759
[TBL] [Abstract][Full Text] [Related]
16. Single-cell and spatial transcriptomics reveal metastasis mechanism and microenvironment remodeling of lymph node in osteosarcoma.
Liu Y; He M; Tang H; Xie T; Lin Y; Liu S; Liang J; Li F; Luo K; Yang M; Teng H; Luo X; He J; Liao S; Huang Q; Feng W; Zhan X; Wei Q
BMC Med; 2024 May; 22(1):200. PubMed ID: 38755647
[TBL] [Abstract][Full Text] [Related]
17. Disulfidptosis-related PABPC3 promotes tumor progression and inhibits immune activity in osteosarcoma.
Cao Y; Wu S; Gu Y; Wong YH; Shi Y; Zhang L
J Gene Med; 2024 Jan; 26(1):e3641. PubMed ID: 38058264
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk of disulfidptosis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in bladder cancer based on a machine learning survival framework.
Zhao S; Wang L; Ding W; Ye B; Cheng C; Shao J; Liu J; Zhou H
Front Endocrinol (Lausanne); 2023; 14():1180404. PubMed ID: 37152941
[TBL] [Abstract][Full Text] [Related]
19. Long Noncoding RNA HNF1A-AS1 Regulates Osteosarcoma Advancement Through Modulating the miR-32-5p/HMGB1 Axis.
Lou P; Ding T; Zhan X
Cancer Biother Radiopharm; 2021 May; 36(4):371-381. PubMed ID: 32706998
[No Abstract] [Full Text] [Related]
20. Overexpression of X-Box Binding Protein 1 (XBP1) Correlates to Poor Prognosis and Up-Regulation of PI3K/mTOR in Human Osteosarcoma.
Yang J; Cheng D; Zhou S; Zhu B; Hu T; Yang Q
Int J Mol Sci; 2015 Dec; 16(12):28635-46. PubMed ID: 26633383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]